Welcome to our dedicated page for Runway Growth Finance SEC filings (Ticker: RWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Runway Growth Finance Corp. (Nasdaq: RWAY), a Maryland-incorporated specialty finance company that operates as a closed-end investment fund and has elected to be regulated as a business development company under the Investment Company Act of 1940. Through these filings, investors can review the company’s regulatory disclosures about its investment portfolio, capital structure, and material corporate events.
Runway Growth Finance files periodic reports such as Forms 10-K and 10-Q, which describe its portfolio of loans and equity-related investments, sector exposures in areas like technology and healthcare, use of leverage, and risk factors. Current reports on Form 8-K, several of which are referenced in the data above, disclose items including quarterly financial results, dividend declarations, portfolio activity, and the entry into a definitive merger agreement to acquire SWK Holdings Corporation, a life science focused specialty finance company.
On this page, users can also find filings related to Runway Growth Finance’s notes due 2027, its status as an emerging growth company, and other capital markets information. Items filed under Regulation FD and other events provide additional context on portfolio updates, conference calls, and transaction announcements. Together, these documents form the primary source of official information about RWAY’s operations, governance, and financial condition.
Stock Titan enhances access to these filings with tools that surface key items such as quarterly and annual reports, material 8-K disclosures, and documents related to significant transactions. This allows readers to review Runway Growth Finance’s SEC reports alongside other market data when evaluating the company.
Runway Growth Finance Corp. has issued $103,250,000 in aggregate principal amount of new 7.25% Notes due February 3, 2031 under a supplemental indenture with U.S. Bank Trust Company. These unsecured notes pay 7.25% annual interest quarterly, starting March 1, 2026, and are redeemable at the company’s option on or after February 3, 2028 at $25 per note plus accrued interest.
The company plans to use the net proceeds to repay debt, including redeeming all outstanding 8.00% Notes due 2027 and all or a portion of the 7.50% Notes due 2027. It has notified trustees of its election to redeem $40,250,000 of the $80,500,000 7.50% Notes and all $51,750,000 of the 8.00% Notes on March 5, 2026 at $25 per note plus accrued interest.
Runway Growth Finance Corp. entered into an underwriting agreement for a public offering of $100.0 million aggregate principal amount of its 7.25% Notes due 2031. The deal was arranged with Oppenheimer & Co. Inc., representing several underwriters, and uses the company’s effective shelf registration.
The company granted the underwriters a 30-day option to buy up to an additional $15.0 million principal amount of these notes to cover overallotments. Closing of the offering is expected on February 3, 2026, subject to customary closing conditions, and the notes constitute a direct financial obligation of the company.
Runway Growth Finance Corp. is issuing $100,000,000 of 7.25% unsecured notes due February 3, 2031, with interest paid quarterly and an expected Nasdaq listing under “RWAYI.” The notes are callable at $25 per note on or after February 3, 2028.
The notes rank pari passu with Runway’s other unsecured debt and are effectively subordinated to $183.0 million of secured borrowings as of January 23, 2026. Net proceeds of about $96.75 million are expected to be used to redeem all outstanding 8.00% December 2027 notes, redeem all or part of the 7.50% July 2027 notes, and for general corporate purposes.
Runway is a BDC and RIC that focuses on senior secured lending to late- and growth-stage companies. As of September 30, 2025, it reported a $946.0 million investment portfolio and $489.5 million of net assets and disclosed preliminary year-end 2025 NAV per share between $13.41 and $13.43. The filing also highlights a pending multi-step merger with SWK Holdings to add a new credit platform, subject to closing conditions and SWK stockholder approval.
Runway Growth Finance Corp., a business development company focused on senior secured loans to high‑growth companies, plans to issue new unsecured notes due 2031. The notes will pay quarterly interest, be issued in $25 denominations, rank equally with the company’s existing unsecured notes and be effectively subordinated to secured debt and all liabilities of subsidiaries. The company intends to list the notes on Nasdaq, with trading expected to begin within 30 days of issuance.
Runway expects to use the proceeds to repay outstanding indebtedness, including redeeming some or all of its 2027 notes, to help finance its planned merger with SWK Holdings Corporation, and for general corporate purposes. It has already repaid its 8.54% Series 2023A notes due 2026 in full. Management also released preliminary estimates for December 31, 2025, net asset value per share between $13.41 and $13.43 and net investment income per share between $0.31 and $0.33, which remain subject to final closing and audit.
Runway Growth Finance Corp. provided preliminary, unaudited estimates for its quarter and year ended December 31, 2025. Management currently expects net asset value per common share to be between $13.41 and $13.43. They also estimate net investment income per common share for the same period will range from $0.31 to $0.33. These figures are management estimates only, have not been audited or reviewed by the company’s independent accounting firm, and may change once closing procedures, final valuations, and the full year-end review are completed.
Runway Growth Finance Corp. (RWAY)1,250,000 shares of Runway Growth common stock on 11/17/2025 in an open market sale coded “S” at a price of $9.05 per share. After this sale, OCM Growth Holdings LLC is shown as beneficially owning 7,029,668 shares directly. The filing is made jointly by OCM Growth Holdings LLC, Oaktree Capital Holdings and Oaktree Capital Group Holdings GP, which each state that they disclaim beneficial ownership beyond their respective economic interests.
Runway Growth Finance discussed Q3 2025 results and its proposed merger to acquire SWK Holdings, a healthcare and life sciences lender. Runway reported total investment income of $36.7 million and net investment income of $15.7 million, completing $128.3 million of funded loans across technology, healthcare and select consumer sectors.
The portfolio had $946 million in fair value, a debt yield of 16.8%, and one non‑accrual loan with a fair value of $2.4 million (0.2% of the portfolio). NAV per share was $13.55; leverage was 0.92x. Liquidity totaled $371.9 million with borrowing capacity of $364.0 million. The board declared a Q4 regular distribution of $0.33 per share; Q3 NII was $0.43 per share with spillover income of $0.53.
The parties announced a NAV‑for‑NAV merger with an estimated purchase price of ~$220 million, including $75.5 million in Runway shares valued at closing NAV and ~$145 million in cash, plus a $9 million cash contribution from the adviser. Runway expects mid‑single digit run‑rate NII accretion in the first full quarter post‑close and to increase healthcare exposure to about 31% from 14%. Closing is anticipated in early 2026.
Runway Growth Finance Corp. announced a proposed merger with SWK Holdings Corporation and outlined expected financial and portfolio impacts. The company anticipates mid single-digit run-rate net investment income (NII) accretion during the first full quarter following closing, with pro forma leverage moving to ~1.1x. Management highlighted potential benefits including enhanced scale, broader funding access, and a lowered risk profile from smaller average loan positions.
Operationally, the portfolio at fair value was $946 million as of September 30, 2025, with a weighted average debt investment yield of 16.83%. For the same period, NAV per share was $13.55 and NII per share was $0.43. The platform reported 98% first lien exposure and a cumulative net loss rate of 0.61% since inception, supported by disciplined underwriting and active monitoring. Management also cited improved trading liquidity and funding flexibility as potential post-combination advantages, subject to completion of the merger and customary conditions.
Runway Growth Finance Corp. filed its quarterly report for the period ended September 30, 2025, detailing a highly diversified portfolio of private company investments. The report focuses on fair value measurements for Level 3 assets, primarily non-control, non-affiliate senior secured loans and related warrants and equity positions.
The portfolio spans multiple industries including application and systems software, healthcare technology and equipment, financial services, data processing, media and entertainment, consumer staples and retail, and technology hardware. Many debt positions are structured as senior secured term loans or revolvers priced at SOFR- or PRIME-based floating rates with floors, plus payment-in-kind (PIK) and end-of-term payment (ETP) components, and long-dated maturities typically extending into 2027–2034.
The company also holds numerous warrants and preferred or common equity positions, often as success fees or earnouts tied to its lending relationships. The cover of the report notes that 36,134,037 shares of common stock were outstanding as of November 4, 2025, and that the common stock and certain notes are listed on the Nasdaq Global Select Market.